NCT05526313
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma，DLBCL, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- West China Hospital Sichuan University Chengdu, Sichuan, China
Clinical trial condition
Diffuse Large B Cell Lymphoma，DLBCL
Explore clinical trials studying Diffuse Large B Cell Lymphoma，DLBCL. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Diffuse Large B Cell Lymphoma，DLBCL trial results
Active, Not Recruiting
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
NCT05563844
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma，DLBCL, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Ruijin Hospital of Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University Chengdu, Sichuan, China